Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre
Firas Constantin Kreeshan, Ali Al‐Janabi, Richard B. Warren, et al.
Dermatology and Therapy (2020) Vol. 11, Iss. 1, pp. 149-160
Open Access | Times Cited: 23

Showing 23 citing articles:

Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors
Richard W. Kim, Megan Lam, Katrina Abuabara, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 2, pp. 179-193
Closed Access | Times Cited: 19
A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis
Masahiro Kamata, Yayoi Tada
JID Innovations (2021) Vol. 1, Iss. 3, pp. 100042-100042
Open Access | Times Cited: 56
Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review
Nicoleta Neagu, Caterina Dianzani, Gianluca Avallone, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 6, pp. 820-835
Open Access | Times Cited: 49
A nationwide 104 weeks real‐world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head‐and‐neck dermatitis
Ida Vittrup, Niels Steen Krogh, Henrik Hedegaard Pliess Larsen, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 5, pp. 1046-1055
Open Access | Times Cited: 39
Biologic Versus Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Clinical Considerations
Sneha Butala, Leslie Castelo‐Soccio, Rishi Seshadri, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 5, pp. 1361-1373
Open Access | Times Cited: 22
Impact of a Decade of Research Into Atopic Dermatitis
Peter D. Arkwright, Jennifer J. Koplin
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 1, pp. 63-71
Open Access | Times Cited: 27
Total flavonoids of sea buckthorn (Hippophae rhamnoides L.) improve MC903-induced atopic dermatitis-like lesions
Yajing Gu, Xinxin Wang, Fang Liu, et al.
Journal of Ethnopharmacology (2022) Vol. 292, pp. 115195-115195
Closed Access | Times Cited: 23
A real-world study of dupilumab in patients with atopic dermatitis including patients with malignancy and other medical comorbidities
Dea Metko, Maha Alkofide, Mohannad Abu‐Hilal
JAAD International (2024) Vol. 15, pp. 5-11
Open Access | Times Cited: 5
Efficacy and Safety Study of Dupilumab in Children with Moderate to Severe Atopic Dermatitis
晓佩 许
Advances in Clinical Medicine (2025) Vol. 15, Iss. 04, pp. 2805-2813
Closed Access
Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry
Martina Kojanová, Milena Tanczosová, Daniela Štrosová, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2578-2586
Closed Access | Times Cited: 15
Facial erythema in patients with atopic dermatitis treated with Dupilumab – a descriptive study of morphology and Aetiology
Jiyoung Ahn, Dong Heon Lee, Chan Ho Na, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 11, pp. 2140-2152
Closed Access | Times Cited: 14
Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study
Bingjing Zhou, Cong Peng, Liqiao Li, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Dupilumab for atopic dermatitis: a real-world Portuguese multicenter retrospective study
Tiago Torres, Maria João Paiva Lopes, Margarida Gonçalo, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2554-2559
Closed Access | Times Cited: 12
An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024
Michael R. Ardern‐Jones, Sara Brown, Carsten Flohr, et al.
British Journal of Dermatology (2024)
Closed Access | Times Cited: 2
Consensus on the therapeutic management of atopic dermatitis ‒ Brazilian Society of Dermatology: an update on phototherapy and systemic therapy using e-Delphi technique
Raquel Leão Orfali, Daniel Lorenzini, Aline Lopes Bressan, et al.
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 6, pp. 814-836
Open Access | Times Cited: 6
Efficacy and Safety of Dupilumab in Clinical Practice: One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre
Maddalena Napolitano, Maria Ferrillo, Cataldo Patruno, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 2, pp. 355-361
Open Access | Times Cited: 13
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
Lawrence F. Eichenfield, April W. Armstrong, Emma Guttman‐Yassky, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 6, pp. 1337-1350
Open Access | Times Cited: 6
Is Dupilumab a chance for patients with moderate to severe atopic dermatitis? Literature review
Paweł Iwańczuk
Journal of Education Health and Sport (2024) Vol. 63, pp. 84-94
Open Access
Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience
Julián Esteban Londoño Hernández, Lucía Cecilia Pérez, Sergio Moreno, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 4, pp. 100763-100763
Open Access | Times Cited: 1
Is dupilumab effective in adult‐onset atopic dermatitis: Real‐life experience of 16 patients
Ece Erbağcı, Neslihan Demirel Öğüt, Sema Koç Yıldırım, et al.
Journal of Cosmetic Dermatology (2022) Vol. 21, Iss. 10, pp. 4852-4857
Closed Access | Times Cited: 2
Consenso sobre o manejo terapêutico da dermatite atópica – Sociedade Brasileira de Dermatologia: atualização sobre fototerapia e terapia sistêmica utilizando o método e‐Delphi
Raquel Leão Orfali, Daniel Lorenzini, Aline Lopes Bressan, et al.
(2023) Vol. 98, Iss. 6, pp. 814-836
Open Access
Total Flavonoids of Sea Buckthorn ( <i>Hippophae Rhamnoides</i> L.) Improve MC903-Induced Atopic Dermatitis-Like Lesions
Yajing Gu, Xinxin Wang, F. H. Liu, et al.
SSRN Electronic Journal (2022)
Closed Access
Dupilumab

Reactions Weekly (2021) Vol. 1848, Iss. 1, pp. 171-171
Closed Access
Page 1

Scroll to top